Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia Read more
Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor Read more
BioCryst Selects Swixx BioPharma as Commercial Partner for ORLADEYO (berotralstat) in Central and Eastern Europe Read more
TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors Read more
Blueprint Medicines Announces FDA Acceptance of Supplemental New Drug Application for AYVAKIT (avapritinib) for the Treatment of Indolent Systemic Mastocytosis Read more
Exegenesis Bio Announces FDA Clearance of Investigational New Drug (IND) Application for EXG102-031; A Novel Gene Therapy for the Treatment of neovascular Age-Related Macular Degeneration (nAMD) Read more
Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its promising DNA vaccine for advanced cervical cancer Read more